Durham, Benjamin H <br/><br/>
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.  [electronic resource] 

 -  Nature medicine  12 2019 
 - 1839-1842 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1546-170X 
<br/><br/><label>Standard No.: </label>10.1038/s41591-019-0653-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aminopyridines--pharmacology<br/>Anaplastic Lymphoma Kinase--genetics<br/>Benzothiazoles--pharmacology<br/>Child<br/>Child, Preschool<br/>Female<br/>Genome, Human<br/>Hematologic Neoplasms--drug therapy<br/>Histiocytosis--drug therapy<br/>Humans<br/>Infant<br/>Male<br/>Mutation<br/>Picolinic Acids--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-ret--genetics<br/>Pyrazoles--pharmacology<br/>Pyridines--pharmacology<br/>Pyrroles--pharmacology<br/>Receptor Protein-Tyrosine Kinases--genetics<br/>Receptors, Granulocyte-Macrophage Colony-Stimulating Factor--genetics<br/>Twins, Monozygotic<br/>Exome Sequencing<br/>Young Adult